Repurposing calcium channel blockers: may be sensible combination with erlotinib for non-small cell lung cancer

This study will be inspiring future prospective studies.
Source: Anti-Cancer Drugs - Category: Cancer & Oncology Tags: Clinical Reports Source Type: research